Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Concord Biotech Balance Sheet Annual
Trade2,073.30 +41.75 (2.06%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Cash | 15.14 | 3.50 | 0.67 | 5.14 |
| Short Term Investments | 266.52 | 136.93 | 73.86 | 141.07 |
| Cashand Short Term Investments | 281.67 | 180.38 | 162.79 | 201.89 |
| Accounts Receivable- Trade Net | 350.84 | 274.55 | 234.30 | 178.98 |
| Total Receivables Net | 378.89 | 323.10 | 260.23 | 231.13 |
| Total Inventory | 215.61 | 213.62 | 197.63 | 154.99 |
| Prepaid Expenses | 7.33 | 5.52 | 4.76 | 4.54 |
| Other Current Assets Total | 12.74 | 5.08 | 7.25 | 14.59 |
| Total Current Assets | 896.23 | 727.70 | 632.67 | 607.15 |
| Property/ Plant/ Equipment Total- Gross | 1,026.63 | 952.79 | 781.40 | 650.16 |
| Accumulated Depreciation Total | -240.15 | -187.31 | -137.85 | -92.41 |
| Property/ Plant/ Equipment Total- Net | 786.48 | 765.48 | 643.56 | 557.75 |
| Intangibles Net | 0.32 | 0.20 | 3.58 | 6.42 |
| Long Term Investments | 3.05 | 10.32 | 2.75 | 3.14 |
| Note Receivable- Long Term | 12.47 | 2.67 | 3.60 | 1.70 |
| Other Long Term Assets Total | 2.16 | 7.62 | 26.64 | 6.39 |
| Total Assets | 1,700.71 | 1,513.98 | 1,312.80 | 1,182.55 |
| Accounts Payable | 94.44 | 93.80 | 83.11 | 46.40 |
| Accrued Expenses | 0.10 | 0.26 | 0.36 | 0.51 |
| Notes Payable/ Short Term Debt | 0.00 | 0.00 | 4.34 | 5.10 |
| Current Portof LT Debt/ Capital Leases | 7.85 | 25.15 | 26.60 | 26.30 |
| Other Currentliabilities Total | 39.77 | 72.64 | 40.77 | 27.43 |
| Total Current Liabilities | 142.16 | 191.84 | 155.17 | 105.74 |
| Long Term Debt | 0.00 | 6.24 | 31.25 | 56.25 |
| Capital Lease Obligations | 1.89 | 0.16 | 0.31 | 1.63 |
| Total Long Term Debt | 1.89 | 6.40 | 31.56 | 57.88 |
| Total Debt | 9.74 | 31.55 | 62.49 | 89.28 |
| Deferred Income Tax | 28.06 | 23.44 | 20.97 | 17.45 |
| Other Liabilities Total | 1.96 | 2.30 | 1.87 | 2.10 |
| Total Liabilities | 174.06 | 223.98 | 209.57 | 183.17 |
| Common Stock Total | 10.46 | 10.46 | 9.51 | 9.51 |
| Additional Paid- In Capital | 81.97 | 81.97 | 82.92 | 82.92 |
| Retained Earnings( Accumulated Deficit) | 1,434.21 | 1,197.57 | 1,010.79 | 906.94 |
| Total Equity | 1,526.65 | 1,290.00 | 1,103.22 | 999.37 |
| Total Liabilities Shareholders' Equity | 1,700.71 | 1,513.98 | 1,312.80 | 1,182.55 |
| Total Common Shares Outstanding | 10.46 | 10.46 | 10.46 | 10.46 |
| Tangible Book Valueper Share Common Eq | 145.90 | 123.29 | 105.11 | 94.91 |
| Cash Equivalents | - | 39.95 | 88.27 | 55.68 |
*All figures in crores except per share values
Concord Biotech Quick Links
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Key Metrics Concord Biotech Shareholdings Concord Biotech Profit Loss Concord Biotech Cashflow Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)